ESC 365 - Late gadolinium enhancement and tissue characterisation: a marker of disease progression, a risk marker or both?

Open Access

Late gadolinium enhancement and tissue characterisation: a marker of disease progression, a risk marker or both?

Session: Hypertrophic cardiomyopathy: The arena where echocardiography and cardiac magnetic resonance are perpetually complementary and on no account competitive

Topic: Imaging of Myocardial Disease

Speaker: Professor J. Bax (Leiden, NL)

Sponsored by Bristol Myers Squibb

Event: EuroEcho 2021

Congress Presentation

About the speaker

Professor Jeroen Bax

Leiden University Medical Center, Leiden (Netherlands (The))

76 presentations

5 followers

4 more presentations in this session

Introduction.

Dynamic and exercise echocardiography.

Speaker: Doctor A. Pantazis (London, GB)

Multimodality imaging for left ventricular hypertrophy.

Speaker: Doctor M. Michels (Rotterdam, NL)

Live Q&A and conclusion.

Access the full session

Hypertrophic cardiomyopathy: The arena where echocardiography and cardiac magnetic resonance are perpetually complementary and on no account competitive

Speakers: Professor J. Bax, Doctor A. Pantazis, Doctor M. Michels

About the event

EuroEcho 2021

9 December - 11 December 2021

Sessions Presentations

Congress

Related content

ESC Premium Access

Ticagrelor monotherapy after percutaneous coronary intervention in patients with concomitant diabetes mellitus and chronic kidney disease: a TWILIGHT substudy

29 August 2021

ESC Premium Access

Will all valve therapy be percutaneous?

27 August 2021

ESC Premium Access

Ticagrelor implementation in PCI-treated ACS patients

27 August 2021

ESC 365 is supported by